Flora Growth Corp. (FLGC): Price and Financial Metrics
FLGC Price/Volume Stats
| Current price | $0.22 | 52-week high | $1.27 |
| Prev. close | $0.23 | 52-week low | $0.17 |
| Day low | $0.22 | Volume | 619,400 |
| Day high | $0.24 | Avg. volume | 1,531,775 |
| 50-day MA | $0.23 | Dividend yield | N/A |
| 200-day MA | $0.45 | Market Cap | 30.34M |
FLGC Stock Price Chart Interactive Chart >
Flora Growth Corp. (FLGC) Company Bio
Flora Growth Corp. cultivates, processes, and supplies medicinal-grade cannabis oil and cannabis for pharmacies, medical clinics, and cosmetic companies. The company was incorporated in 2019 and is headquartered in Toronto, Canada.
Latest FLGC News From Around the Web
Below are the latest news stories about FLORA GROWTH CORP that investors may wish to consider to help them evaluate FLGC as an investment opportunity.
Flora Growth Reports First Quarter 2023 Financial ResultsFORT LAUDERDALE, Fla., May 15, 2023--Flora Growth Corp. (NASDAQ: FLGC) ("Flora'' or the "Company"), a global cultivator, manufacturer, and distributor of cannabis products and brands, reported today its financial and operating results for the quarter ended March 31, 2023. All financial information is provided in U.S. dollars unless indicated otherwise. |
Flora Growth Corp. Announces the Appointment of Hussein Rakine as CEO and Member of the Board of DirectorsFORT LAUDERDALE, Fla., April 18, 2023--Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company") a leading cultivator, manufacturer and distributor of global cannabis products and brands, today announced that its board of directors (the "Board") accepted the resignation of Luis Merchan as Chairman of the Board and the Company’s Chief Executive Officer (CEO). To fill the vacancies created by Mr. Merchan’s resignation, the Board has appointed JustCBD founder, Hussein Rakine, as CEO and member o |
FLGC: Company Optimistic About Growth of the Medical Cannabis SectorBy M. Marin NASDAQ:FLGC READ THE FULL FLGC RESEARCH REPORT Flora views recent certification of Flora Lab 4 as a positive Flora Growth Corp. (NASDAQ:FLGC) believes that the recent certification of Flora Lab 4, which specializes in prescription cannabis formulations, is a positive. Flora Lab 4 intends to begin offering its cannabis formulations & services for third parties. Flora expects Lab 4, |
Flora Growth Corp. (NASDAQ:FLGC) Q4 2022 Earnings Call TranscriptFlora Growth Corp. (NASDAQ:FLGC) Q4 2022 Earnings Call Transcript April 3, 2023 Jessie Casner: Before we begin, I’d like to note that the webcast is being recorded and will be published for viewing shortly after the end of the webcast. On the call with me today are Luis Merchan, Chief Executive Officer and Chairman of […] |
Flora Growth Receives CGMP Certification of Compound Formulation Lab; Launches Prescription Cannabis Medicines in ColombiaFORT LAUDERDALE, Fla., April 04, 2023--Flora Growth Corp. (NASDAQ: FLGC) ("Flora'' or the "Company"), a leading cultivator, manufacturer and distributor of global cannabis products and brands, announced today the certification of its Bogotá-based compound formulation laboratory, Flora Lab 4, following the required regulatory inspection by INVIMA (Colombia’s FDA). The inspection certifies the lab as meeting Current Good Manufacturing Practices standards as determined by INVIMA. Flora Lab 4 specia |
FLGC Price Returns
| 1-mo | 22.22% |
| 3-mo | -46.34% |
| 6-mo | -50.00% |
| 1-year | -76.60% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -3.34% |
| 2022 | -87.21% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...